EGFR and breast neoplasm: Breast tumors with higher HPRT1 expression showed a worse clinical outcome, and its knockdown in the triple-negative basal-type MDAMB231 cells showed significant alteration in the expression of genes involved in Notch and ErbB signaling pathways (Figure 2 and Figure 3).